PMID: 8999490Dec 10, 1996Paper

Modern tumor therapy as seen in melanoma

Praxis
R DummerG Burg

Abstract

Modern therapy of melanoma should always consider the prognosis of the disease. Primary low-risk melanomas with tumor-thickness below 1 mm can be treated by surgery with a safety margin of 1 cm. If the tumor-thickness is more than 2 mm the safety margin should be at least 3 cm. After the resection of lymph node metastases adjuvant treatment using Interferon-alpha should be considered. Palliative therapy of metastases includes surgery, radiotherapy and chemoimmunotherapy. Recent progress in understanding the immunobiology of melanoma and the development of gene therapy has offered new perspectives for future therapeutical intervention.

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Therapeutische Umschau. Revue thérapeutique
R DummerG Burg
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
R DíazA Tormo
Neurologic Clinics
P Y WenJ S Loeffler
© 2022 Meta ULC. All rights reserved